What question did this study set out to answer?

To describe the successful application of a completely non-fluoroscopic catheter ablation procedure in a pregnant woman with drug-refractory supraventricular tachycardia.

May 4, 2022Heart Vessels and TransplantationOpen Access

Zero-fluoroscopy approach for ablation in Wolf -Parkinson – White syndrome during pregnancy

View Full Paper

Ask AI

Bookmark

Why the study?

Paroxysmal supraventricular tachycardias in pregnancy pose therapeutic challenges due to antiarrhythmic drug limitations and radiation exposure risks from catheter ablation.

Does zero-fluoroscopy catheter ablation using 3-D mapping safely treat refractory supraventricular tachycardia in a pregnant woman with Wolff-Parkinson-White syndrome?

Comparison

Catheter ablation of a left lateral accessory pathway without fluoroscopy

Design

Case report

Authors

URUlises RojelHeart Rhythm Society ILIngrid Lopez EGErick Gomez

Discussion

Member takes

Implication

May support radiation-free ablation in pregnant WPW; leaves open need for prospective confirmation before practice change.

Key Points

To describe the successful application of a completely non-fluoroscopic catheter ablation procedure in a pregnant woman with drug-refractory supraventricular tachycardia.
Evaluated a pregnant patient presenting with Wolff-Parkinson-White syndrome and recurrent episodes of paroxysmal supraventricular tachycardia refractory to antiarrhythmic medications.
Conducted catheter ablation targeting a left lateral accessory pathway entirely without fluoroscopy to eliminate radiation risks to the fetus and mother.
Successfully localized and ablated the left lateral accessory pathway with zero fluoroscopic exposure.
Resolved recurrent tachycardia without procedural complications or exposure of the mother and fetus to ionizing radiation.

Structured PICO

Does zero-fluoroscopy catheter ablation using 3-D mapping safely treat refractory supraventricular tachycardia in a pregnant woman with Wolff-Parkinson-White syndrome?

Population

24-year-old pregnant woman (first trimester, eighth week) with Wolff-Parkinson-White (WPW) syndrome and recurrent supraventricular tachycardia refractory to antiarrhythmic drug therapy (n=1).

Intervention

Zero-fluoroscopy catheter ablation of a left lateral accessory pathway using a 3-D mapping system (Ensite Precision) and radiofrequency energy (30-watts/70°C).

Outcome

Successful ablation of the accessory pathway (disappearance of delta wave and normalization of PR interval).surrogate

Zero-fluoroscopy catheter ablation using 3-D mapping is a feasible and safe therapeutic option for pregnant women with refractory supraventricular tachycardia due to Wolff-Parkinson-White syndrome.

Cite This Study

Rojel et al. (2022) studied this question.

synapsesocial.com/papers/6a81e326ffaafd634258d170 https://doi.org/10.24969/hvt.2022.316

View Full Paper

Ask AI

Bookmark

Zero-fluoroscopy approach for ablation in Wolf -Parkinson – White syndrome during pregnancy

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Zero-fluoroscopy approach for ablation in Wolf -Parkinson – White syndrome during pregnancy

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider